ArticleThe Journal of infectious diseases2023

Monitoring of Adverse Events in Recipients of the 2-Dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination Campaign.

Julien Nyombayire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.